It has been reported that overexpression of CCNB1 was correlated with adverse pathological types and clinical outcomes [32, 33], such as BC [34–36], colon adenocarcinoma [31], non-small cell lung cancer [37] and esophageal squamous cell cancer [38]. This evidence concerns the gene CCNB1 and non-small cell lung carcinoma.